Genetic Complementation Results in Augmented Autoantibody Responses to Lupus-Associated Antigens
Open Access
- 1 September 2009
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 183 (5) , 3505-3511
Abstract
Lupus-prone female New Zealand Mixed (NZM)2328 mice develop high titers of anti-nuclear and anti-dsDNA autoantibodies. Despite high expression of type I IFNs, these mice do not develop autoantibodies to the small nuclear ribonucleoprotein (snRNP) complex. Thus, additional genetic factors must regulate the generation of anti-snRNP autoantibodies. In contrast, despite much lower expression of type 1 IFNs, the diabetes-prone NOD mice spontaneously make anti-snRNP autoantibodies, albeit at a low incidence. To determine whether combination of high type I IFN response of NZM mice with appropriate susceptibility genes of NOD mice would result in anti-snRNP Ab response, cohorts of (NZM2328 × NOD)F1 mice were generated and characterized for development of autoimmunity. In comparison with parental strains, the PBMCs from F1 mice showed intermediate expression of type I IFN-responsive genes and augmented expression of IL-6 transcripts. TLR7 expression was similar in all strains. The F1 mice had very high incidence and titer of anti-snRNP autoantibodies, anti-nuclear Abs, and anti-dsDNA autoantibodies. The levels of anti-snRNP autoantibody correlated with the expression levels of type I IFN-responsive genes. None of the F1 mice developed diabetes, and only female mice developed severe renal disease. Our data demonstrate that only in presence of appropriate susceptibility genes, anti-snRNP autoantibodies are induced and type I IFNs amplify this response. A synergy between IL-6 and type I IFNs might be critical for amplifying overall autoantibody responses in systemic lupus erythematosus. In NZM/NOD F1 mouse, genetic complementation between NZM and NOD genes leads to expression of phenotypes similar to those seen in certain lupus patients.Keywords
This publication has 27 references indexed in Scilit:
- Autophagy connects antigen receptor signaling to costimulatory signaling in B lymphocytesAutophagy, 2009
- TLR7-dependent and FcγR-independent production of type I interferon in experimental mouse lupusJournal of Experimental Medicine, 2008
- The B Cell Receptor Governs the Subcellular Location of Toll-like Receptor 9 Leading to Hyperresponses to DNA-Containing AntigensImmunity, 2008
- Control of Toll-like Receptor 7 Expression Is Essential to Restrict Autoimmunity and Dendritic Cell ProliferationImmunity, 2007
- Deficiency of the type I interferon receptor protects mice from experimental lupusArthritis & Rheumatism, 2007
- Variation in the relative copy number of the TLR7 gene in patients with systemic lupus erythematosus and healthy control subjectsArthritis & Rheumatism, 2007
- High serum IFN-α activity is a heritable risk factor for systemic lupus erythematosusGenes & Immunity, 2007
- A SmD Peptide Induces Better Antibody Responses to Other Proteins within the Small Nuclear Ribonucleoprotein Complex than to SmD Protein via Intermolecular Epitope SpreadingThe Journal of Immunology, 2007
- Guidelines for immunologic laboratory testing in the rheumatic diseases: Anti‐Sm and anti‐RNP antibody testsArthritis Care & Research, 2004
- NZM2328: A New Mouse Model of Systemic Lupus Erythematosus with Unique Genetic Susceptibility LociClinical Immunology, 2001